Nasdaq Stockholm

Egetis Therapeutics AB (publ)

ISIN SE0003815604Filings at the FI

At a glance

Most recent filing on September 3, 2026 — a sale by Christian Sonesson on Sep 2, 2026.

We hold 52 visible filings, going back to March 6, 2020.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

What is a MAR filing?

5 of 52 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings at this company, out of 52. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Christian Sonesson Other member of the administrative, management or supervisory body
4,616 SEKOpen-market sale
TradedSep 2, 2026FiledSep 3, 2026
Mats Blom Chair of the board
672,000 SEKOpen-market buy
TradedJan 14, 2026FiledJan 16, 2026
Yilmaz Mahshid Chief financial officer
232,266 SEKOpen-market buy
TradedNov 26, 2025FiledDec 1, 2025
Karl Hård af Segerstad Other member of the administrative, management or supervisory body
114,500 SEKOpen-market buy
TradedNov 27, 2025FiledDec 1, 2025
Karl Hård af Segerstad Other member of the administrative, management or supervisory body
118,250 SEKOpen-market buy
TradedNov 28, 2025FiledDec 1, 2025